Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,593 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and Validation of a Lifetime Risk Model for Kidney Failure and Treatment Benefit in Type 2 Diabetes: 10-Year and Lifetime Risk Prediction Models.
Østergaard HB, Read SH, Sattar N, Franzén S, Halbesma N, Dorresteijn JAN, Westerink J, Visseren FLJ, Wild SH, Eliasson B, van der Leeuw J. Østergaard HB, et al. Among authors: sattar n. Clin J Am Soc Nephrol. 2022 Dec;17(12):1783-1791. doi: 10.2215/CJN.05020422. Epub 2022 Nov 4. Clin J Am Soc Nephrol. 2022. PMID: 36332974 Free PMC article.
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S, Dyal L, Branch K; AMPLITUDE-O Trial Investigators. Gerstein HC, et al. Among authors: sattar n. N Engl J Med. 2021 Sep 2;385(10):896-907. doi: 10.1056/NEJMoa2108269. Epub 2021 Jun 28. N Engl J Med. 2021. PMID: 34215025 Free article. Clinical Trial.
Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes.
Regan JA, Mentz RJ, Nguyen M, Green JB, Truby LK, Ilkayeva O, Newgard CB, Buse JB, Sourij H, Sjöström CD, Sattar N, McGarrah RW, Zheng Y, McGuire DK, Standl E, Armstrong P, Peterson ED, Hernandez AF, Holman RR, Shah SH. Regan JA, et al. Among authors: sattar n. JCI Insight. 2023 Sep 8;8(17):e168563. doi: 10.1172/jci.insight.168563. JCI Insight. 2023. PMID: 37552540 Free PMC article.
Putting More Weight on Obesity Trials in Heart Failure.
Harrington J, Sattar N, Felker GM, Januzzi JL, Lam CSP, Pagidipati NJ, Pandey A, Van Spall HGC, McGuire DK. Harrington J, et al. Among authors: sattar n. Curr Heart Fail Rep. 2024 Jun;21(3):194-202. doi: 10.1007/s11897-024-00655-z. Epub 2024 Apr 15. Curr Heart Fail Rep. 2024. PMID: 38619690 Review.
Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI).
Carberry J, Petrie MC, Lee MMY, Stanley B, Brooksbank KJM, Campbell RT, Good R, Jhund PS, Kellman P, Lang NN, Lindsay MM, Mangion K, Gardner RS, Mark PB, Meyer B, O'Donnell J, Orchard V, Shaukat A, Watkins S, McConnachie A, McMurray JJV, Welsh P, Sattar N, Berry C, Docherty KF. Carberry J, et al. Among authors: sattar n. Eur J Heart Fail. 2024 Dec 15. doi: 10.1002/ejhf.3560. Online ahead of print. Eur J Heart Fail. 2024. PMID: 39675781
Contribution of infection to mortality in people with type 2 diabetes: a population-based cohort study using electronic records.
Carey IM, Critchley JA, Chaudhry UAR, DeWilde S, Limb ES, Bowen L, Audi S, Cook DG, Whincup PH, Sattar N, Panahloo A, Harris T. Carey IM, et al. Among authors: sattar n. Lancet Reg Health Eur. 2024 Nov 27;48:101147. doi: 10.1016/j.lanepe.2024.101147. eCollection 2025 Jan. Lancet Reg Health Eur. 2024. PMID: 39670170 Free PMC article.
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials.
Badve SV, Bilal A, Lee MMY, Sattar N, Gerstein HC, Ruff CT, McMurray JJV, Rossing P, Bakris G, Mahaffey KW, Mann JFE, Colhoun HM, Tuttle KR, Pratley RE, Perkovic V. Badve SV, et al. Among authors: sattar n. Lancet Diabetes Endocrinol. 2025 Jan;13(1):15-28. doi: 10.1016/S2213-8587(24)00271-7. Epub 2024 Nov 25. Lancet Diabetes Endocrinol. 2025. PMID: 39608381
Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study.
Ho FK, Dale C, Mizani MA, Bolton T, Pearson ER, Valabhji J, Delles C, Welsh P, Nakada S, Mackay D, Pell JP, Tomlinson C, Petersen SE, Bray B, Ashworth M, Rahimi K, Mamas M, Halcox J, Sudlow C, Sofat R, Sattar N; CVD-COVID-UK/COVID-IMPACT Consortium. Ho FK, et al. Among authors: sattar n. PLoS Med. 2024 Nov 26;21(11):e1004485. doi: 10.1371/journal.pmed.1004485. eCollection 2024 Nov. PLoS Med. 2024. PMID: 39591388 Free PMC article.
1,593 results